New data demonstrated that a cardiovascular polypill—combining a statin with 3 half-standard ... by effectively controlling CVD risk factors in populations with limited health care access ...
3, 2025 — Low-density lipoproteins (LDL) -- commonly known as bad cholesterol -- have long been on scientists' radar as a major contributor to heart disease ... Time Tied to Risk of Dementia ...
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...